Showing 661 - 680 results of 61,030 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (we decrease)) ))', query time: 1.03s Refine Results
  1. 661
  2. 662
  3. 663
  4. 664
  5. 665
  6. 666
  7. 667
  8. 668
  9. 669
  10. 670
  11. 671
  12. 672
  13. 673
  14. 674
  15. 675
  16. 676
  17. 677

    PAS staining of intestinal sections from <i>T. spiralis</i>-infected mice pretreated with DAS and Y27632. by Wen Wen Zheng (17721404)

    Published 2025
    “…<b>B</b>: Number of intestinal goblet cells (n = 3). <b>C</b>: Muc2 mRNA transcription level (n = 3). <b>D</b>: Muc5ac mRNA transcription level (n = 3). …”
  18. 678

    CO<sub>2</sub> Reduction Characteristics at Pt<sub>0.5</sub>Ru<sub>0.5</sub>/C Cathode of H<sub>2</sub>-CO<sub>2</sub> Polymer Electrolyte Fuel Cell (Supporting Information) by Shofu MATSUDA (20819648)

    Published 2025
    “…In this study, we investigated the CO<sub>2</sub> reduction using a Pt<sub>0.5</sub>Ru<sub>0.5</sub>/C electrocatalyst in order to realize a continuous CH<sub>4</sub> production. …”
  19. 679

    Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV‑2 Main Protease by Julia M. Flynn (16475720)

    Published 2023
    “…Drugs that target the main protease (M<sup>pro</sup>) of SARS-CoV-2 are effective therapeutics that have entered clinical use. …”
  20. 680

    Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV‑2 Main Protease by Julia M. Flynn (16475720)

    Published 2023
    “…Drugs that target the main protease (M<sup>pro</sup>) of SARS-CoV-2 are effective therapeutics that have entered clinical use. …”